Abstract:Multidrug-resistant (MDR) bacteria-induced infections are becoming challenging issues threatening human health and life. Current antibiotics can hardly tackle this problem. Herein, we present a strategy to prepare mercaptophenylboronic acid (MBA)-activated gold nanoparticles (Au NPs) as an antibacterial agent against MDR bacteria. Both Au NPs and MBA cannot serve as antibiotics. However, when MBA attaches on Au NPs, the Au_MBA NPs show potent antibacterial activities against Gram-positive MDR clinical isolates (e.g., MDR Staphyloccocus aureus, MDR S. aureus; MDR Staphyloccocus epidermidis, MDR S. epidermidis). Furthermore, Au_MBA NPs show an extremely high median lethal dose (LD50,i.v., 960 mg/kg), which is much higher than those of most of the clinically used antibiotics. As an application example, we dope Au_MBA NPs with electrospun poly(ε-caprolactone) (PCL)/gelatin nanofibrous membranes as wound dressings, which show striking ability to remedy S. aureus- or MDR S. aureus-infected full-thickness skin wounds on rats. Our study provides a novel strategy for treating MDR bacteria-infected wounds in a simple, low-cost, and efficient way, which holds promise for broad clinical applications.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c12597?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c12597</a>.Antibacterial activities of mercaptophenylboronic acid (Table S1); antibiotic profile of MDR strains (Table S2); antibacterial activities of Au_MBA NPs and vancomycin indicated by MIC (μg/mL) (Table S3); antibacterial activities of mercaptophenylboronic acid indicated by MIC (μg/mL) (Table S4); high-resolution TEM image of an Au_4MBA NPs (Figure S1); XRD analysis of Au NPs and Au_4MBA NPs (Figure S2); characterization of Au_3MBA NPs and Au_4MBA NPs after storage at 4 °C for 6 months (Figure S3); macrophotography of the bacterial suspensions treated by 3MBA, 4MBA, and Au NPs (Figure S4); antibacterial activity of the Au NPs in different bacterial suspensions (Figure S5); high-resolution TEM image of Au_4MBA NPs with low MBA loading (Figure S6); observation of Au NPs-induced permeability of bacterial cell membranes via PI staining (Figure S7); TEM mapping of the distribution of Au_MBA NPs on S. aureus (Figure S8); hemolysis test of 3MBA, 4MBA, and Au NPs (Figure S9); cytotoxicity assay on MDCK cells (Figure S10); LD50,i.v. test of Au_4MBA NPs (Figure S11); characterization of the ES PG and PGA membranes (Figure S12); characterization of ES PGA nanofibers (Figure S13); antimicrobial activity of ES PG and PGA nanofibrous membranes (Figure S14); in vitro biocompatibility of the ES PG and PGA membranes (Figure S15); and hemolysis test of water, gauze, PG, and PGA with rat blood (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c12597/suppl_file/am0c12597_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Multivalent Aminosaccharide-Based Gold Nanoparticles as Narrow-Spectrum Antibiotics in Vivo

Fungus-mediated Biosynthesis of Gold Nanoparticles with Synergistic Antifungal Activity Against Multidrug-Resistant Candida Albicans

Integration of Antimicrobial Peptides and Gold Nanorods for Bimodal Antibacterial Applications.

Infection Microenvironment-Responsive Multifunctional Peptide Coated Gold Nanorods For Bimodal Antibacterial Applications

Gold Nanoclusters for Targeting Methicillin‐Resistant Staphylococcus Aureus in Vivo

Mercaptopyrimidine-Conjugated Gold Nanoclusters As Nanoantibiotics for Combating Multidrug-Resistant Superbugs

Pharmaceutical Intermediate-Modified Gold Nanoparticles: Against Multidrug-Resistant Bacteria and Wound-Healing Application via an Electrospun Scaffold

Mercaptophenylboronic Acid-Activated Gold Nanoparticles as Nanoantibiotics against Multidrug-Resistant Bacteria

Biosynthesis Strategy of Gold Nanoparticles and Biofabrication of a Novel Amoxicillin Gold Nanodrug to Overcome the Resistance of Multidrug-Resistant Bacterial Pathogens MRSA and E. coli

Gold Nanoparticles Bearing a Clinically Used Non-antibiotic Drug for Combating Multi-drug Resistant Bacteria

Versatility of Targeted Antibiotic-Loaded Gold Nanoconstructs for the Treatment of Biofilm-Associated Bacterial Infections.

Small Molecule-Capped Gold Nanoclusters for Curing Skin Infections

Gold Nanoclusters Treat Intracellular Bacterial Infections: Eliminating Phagocytic Pathogens and Regulating Cellular Immune Response

Antibacterial Mechanism of d-Cysteine/Polyethylene Glycol-Functionalized Gold Nanoparticles and Their Potential for the Treatment of Bacterial Infections

Synergistic Antibacterial Effects of Amoxicillin and Gold Nanoparticles: A Therapeutic Option to Combat Antibiotic Resistance

Protein-reduced Gold Nanoparticles Mixed with Gentamicin Sulfate and Loaded into Konjac/gelatin Sponge Heal Wounds and Kill Drug-Resistant Bacteria.

Evaluation of the in Vivo Behavior of Antibacterial Gold Nanoparticles for Potential Biomedical Applications.

Ellagic acid-modified gold nanoparticles to combat multi-drug resistant bacterial infections in vitro and in vivo

Enhancement of Vancomycin Potential against Pathogenic Bacterial Strains via Gold Nano-Formulations: A Nano-Antibiotic Approach

N-Heterocyclic Molecule-Capped Gold Nanoparticles As Effective Antibiotics Against Multi-Drug Resistant Bacteria.

Multifunctional Gold Nanozyme-Engineered Amphotericin B for Enhanced Antifungal Infection Therapy